Azilsartan Kamedoxomil Patent Expiration
Azilsartan Kamedoxomil is Used for lowering blood pressure. It was first introduced by Azurity Pharmaceuticals Inc
Azilsartan Kamedoxomil Patents
Given below is the list of patents protecting Azilsartan Kamedoxomil, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Edarbi | US9066936 | Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent | Mar 26, 2028 | Azurity |
Edarbi | US7157584 | Benzimidazole derivative and use thereof |
May 22, 2025
(Expired) | Azurity |
Edarbi | US7572920 | Benzimidazole derivative and use as a II receptor antagonist |
Jan 07, 2025
(Expired) | Azurity |
Edarbi | US5958961 | Pharmaceutical composition for angiotensin II-mediated diseases |
Jun 06, 2014
(Expired) | Azurity |
Edarbi | US5583141 | Heterocyclic compounds and their use as angiotensin antagonists |
Dec 10, 2013
(Expired) | Azurity |
Azilsartan Kamedoxomil's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List